| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | 216830 | 001 | NDA | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 20MG/250ML (0.08MG/ML) | Yes | Yes | 2025/05/30 | 2025/05/30 | DR REDDYS LABS SA | Prescription |
| NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | 220243 | 001 | ANDA | NICARDIPINE HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | 20MG/200ML (0.1MG/ML) | No | No | 2025/10/22 | 2025/10/22 | CAPLIN | Prescription |
| NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | 220243 | 002 | ANDA | NICARDIPINE HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | 40MG/200ML (0.2MG/ML) | No | No | 2025/10/22 | 2025/10/22 | CAPLIN | Prescription |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 219619 | 001 | ANDA | CALCIUM GLUCONATE | SOLUTION;INTRAVENOUS | 1GM/50ML (20MG/ML) | No | No | 2025/12/30 | 2025/12/30 | SAGENT | Prescription |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 219619 | 002 | ANDA | CALCIUM GLUCONATE | SOLUTION;INTRAVENOUS | 2GM/100ML (20MG/ML) | No | No | 2025/12/30 | 2025/12/30 | SAGENT | Prescription |